Lexicon Pharmaceuticals | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Abbott USD 3.05B 144M 2025-03
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
Illumina USD 247M 16M 2025-03
Insmed USD 147.54M 5.03M 2025-03
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
J&J USD 5.11B 1.34B 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
MannKind USD 25.01M 1.04M 2025-03
Merck USD 2.53B 319M 2025-03
Moderna USD 212M 139M 2025-03
Novartis USD 3.5B 368M 2024-12
PTC Therapeutics USD 161.92M 77.24M 2025-03
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
Thermo Fisher Scientific USD 1.72B 487M 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
United Therapeutics USD 170.1M 7.6M 2025-03



Lexicon Pharmaceuticals Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.